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Autosomal-dominant familial hematuria with retinal arteriolar
tortuosity and contractures: A novel syndrome.
Background. Autosomal-dominant forms of hematuria have
been mostly related to mutations in the COL4A3/COL4A4
genes. Patients with thin basement membrane (BM) disease
do not have extrarenal manifestations, while those with Alport
syndrome often present with hearing loss, anterior lenticonus,
and dot-and-fleck retinopathy.
Methods. We performed a phenotypic study and a candi-
date gene approach in a four-generation family presenting
with autosomal-dominant hematuria associated with extrarenal
manifestations. Renal biopsy was analyzed for determination
of BM thickness and expression of chains of type IV collagen.
Linkage to 18 candidate genes/loci was investigated using poly-
morphic microsatellite markers.
Results. In all affected patients, hematuria without protein-
uria was associated with muscular contractures and retinal ar-
terial tortuosities responsible for retinal hemorrhages. Cardiac
arrythmia, Raynaud phenomena, and brain MRI abnormali-
ties were also observed. Despite the presence of red cells in
tubule sections, no glomerular abnormalities were found by
electron microscopy. Expression of type IV collagen chains and
glomerular BM thickness was normal. We searched for a molec-
ular defect affecting either BM or angiogenesis. Linkage anal-
yses of genes encoding BM components (COL4A3/COL4A4,
COL6A1, COL6A2, COL6A3, FBLN1), and angiogenic fac-
tors or their receptors (VHL, ANPT1, ANPT2, TIE, TEK,
NOTCH2, NOTCH3, NOTCH4, DLL4, JAG1, JAG2) and of
the facio-sapulo-humeral dystrophy and 3q21 loci failed to show
segregation of the disease with those gene loci.
Conclusion. We have identified a new inherited hematuria
syndrome associated with retinal vessel tortuosities and con-
tractures. We recommend performing a fundus examination in
patients with familial hematuria and episodes of visual impair-
ment, as well as a urinary analysis in patients with retinal arterial
tortuosity or congenital muscular contractures.
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Familial hematuria syndromes are inherited glomeru-
lar diseases characterized by ultrastructural abnormali-
ties of the glomerular basement membrane (GBM). They
include Alport syndrome (AS) and benign familial hema-
turia (BFH), also referred to as thin basement membrane
disease. AS is usually X-linked, but autosomal-dominant
and recessive forms have also been described [1]. BFH
is an inherited disorder transmitting as an autosomal-
dominant trait and characterized by persistent hematuria,
rarely associated with proteinuria, hypertension, or pro-
gression to end-stage renal disease [2, 3]. Patients with
BFH do not have extrarenal manifestations, while those
with AS often present with high-tone sensorineural hear-
ing loss, anterior lenticonus, and dot-and-fleck retinopa-
thy. In AS as well as in BFH, one assumes that GBM
defects account for abnormal presence of red blood
cells in the Bowman’s space and in tubular segments.
However, ultrastructural examination has exceptionally
shown red blood cells traversing through the glomeru-
lar capillary wall, despite extensive use of electron mi-
croscopy in those hereditary diseases [4].
Defects of gene that encode the a5 chain of type
IV collagen were first identified in X-linked AS (MIM
# 301050) [5]. Mutations in the genes of a3 and a4
chains of type IV collagen were subsequently reported
in patients with the autosomal-recessive form of AS
(MIM # 203780) [1, 6]. More recently, linkage with the
COL4A3/COL4A4 locus and mutations affecting either
COL4A3 or COL4A4 genes were also identified in kin-
dreds presenting with BFH (MIM # 141200) [6–11] and
with autosomal-dominant AS (MIM # 104200) [12]. How-
ever, in many families with BFH, hematuria does not
segregate with the COL4A3/COL4A4 locus. Although
these families may still have mutations in the COL4A3
and COL4A4 genes because of de novo mutations, in-
complete penetrance, or coincidental hematuria in family
members who do not harbor the mutation, BFH that does
not segregate with the COL4A3/COL4A4 locus might be
explained by mutations in a novel gene.
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Fig. 1. Pedigrees of the family. Affected patients, presenting hema-
turia, retinal arteriolar tortuosities, and contractures, are indicated by
black symbols. DNA of patients II-3, III-1, III-2, III-3, III-5, IV-1, IV-2,
and IV-4 was available for haplotype analysis.
We first report an inherited autosomal-dominant
hematuria syndrome in a four-generation family not
linked to the COL4A3/COL4A4 locus and with no GBM
ultrastructural abnormalities. This syndrome is remark-
able for the association of hematuria with systemic non-
renal signs that cosegregate with the renal disease, includ-
ing muscular contractures, arteriolar retinal tortuosities
responsible for repeated, benign hemorrhages, brain vas-
cular abnormalities, and hypogammaglobulinemia. The
presence of those unusual extrarenal manifestations led
us to perform gene linkage studies focused on candidate
genes encoding GBM components or involved in vascu-
logenesis or angiogenesis processes.
METHODS
Patients
The pedigree of our French Caucasian family is shown
in Figure 1. Six affected members from the third and the
fourth generations were investigated in our Department
at Tenon Hospital. Partial medical records of the affected
patients of the first and the second generations were also
available.
Histologic study
A renal biopsy was performed in patient IV-1 and
processed for light microscopy, immunofluorescence, and
electron microscopic studies according to standard pro-
cedures used in our laboratory [13]. In addition, 3 lm
frozen sections of the kidney biopsy specimen were incu-
bated with monoclonal antibodies to the a1, a3, and a5
chains of type IV collagen (Alport syndrome diagnostic
kit, Wieslab AB, Lund, Sweden), then with fluoroscein
isothiocyanate (FITC)-labeled secondary antimouse an-
tibody (Dako, Carpinteria, CA, USA). The thickness of
the GBM was measured on ×15,000 power micrographs.
A total of 50 measurements in five loops was done.
Genetic linkage analyses
Venous blood samples from family members II-3, III-
1, III-2, III-3, III-4, IV-1, IV-2, and IV-4 were obtained
after informed consent, according to the French legisla-
tion. Genomic DNA was prepared according to standard
methods. We tested our family for linkage to 18 gene
loci (Table 1). Haplotype analysis was performed using
polymorphic microsatellite markers spanning the genetic
interval of each candidate gene and locus.
RESULTS
Clinical study
Pedigree. As depicted in the family tree (Fig. 1), the
disease transmitted as an autosomal dominant trait. All
affected patients presented with the association of renal
involvement, retinal arterial tortuosities, and muscular
contractures.
Renal involvement. Patients I-2 and II-2 presented
with end-stage renal disease of unknown origin, which oc-
curred after a septic shock and a postoperative shock, re-
spectively. All affected patients in generations III and IV
had isolated microscopic hematuria of more than 100,000
urinary red cells/mL. Gross episodes occurred in three
patients. In the hematuric patients, proteinuria was <300
mg/day, and blood pressure and glomerular filtration rate
were within the normal range. Renal CT scan demon-
strated bilateral small cysts in three patients (II-2, III-
1, III-3). A renal biopsy was performed in patient IV-1
(Fig. 2). Light microscopy showed no glomerular ab-
normalities, but disclosed red blood cells filling in some
tubular lumens, thus confirming the glomerular origin of
hematuria (Fig. 2A). No abnormal immunoglobulin or
complement component deposits were detected by stan-
dard immunofluorescence methods. Indirect immunoflu-
orescence study of the renal expression of the type IV
collagen a1 (not shown), a3 (Fig. 2C), and a5 (Fig. 2D)
chains was also normal. Electron microscopy examina-
tion of the kidney specimen did not show significant
glomerular abnormality (Fig. 2B). The GBM appearance
was globally normal, but with focal areas of dense fold-
ing. The average GBM thickness was 400 nm, within the
normal range for gender and age [15]. No ultrastruc-
tural abnormality of podocytes and endothelial cells was
observed.
Ocular involvement
All affected patients showed retinal arteriolar tortu-
osities in both eyes. They experienced episodes of super-
ficial intraretinal hemorrhages responsible for transient
visual impairment, but resolving spontaneously without
visual sequelae. Funduscopic examination and fluores-
cein angiography revealed the presence of bilateral tor-
tuous retinal arteriolar vessels, especially in the macular
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Table 1. List, distribution, and function of candidate genes tested by microsatellite analysis
Gene/locus Protein Distribution/function Human genetic disease Microsatellite markers
BM components
COL4A3
COL4A4
a3 and a4 chains of
type IV collagen
GBM -AR forms of AS
-AD forms of AS
-BFH
D2S351, TOSHIO,
D2S159, D2S401[9]
COL6A1
COL6A2
a1, a2 of type VI
collagen
BM and ECM including
GBM and mesangium
AD myopathy with
contractures (Bethlem
myopathy)
D21S1255, D21S266,
D21S1260
COL6A3 a3 chains of type VI
collagen
BM and ECM including
GBM and mesangium
AD myopathy with
contractures (Bethlem
myopathy)
D2S2348, D2S345, D2S338
LAMA5 a5 laminin BM D20S171, D20S173
FBLN1 Fibulin-1 BM D22S423, D22S274
Angiogenic proteins/receptors
ANGPT1 Angiopoietin-1 Mesenchyme surrounding
developing vessels. Role
in late stages of
vasculogenesis
D8S556, D8S1703,
D8S1830
ANGPT2 Angiopoietin-2 Role in vascular
remodelling
D8S1742, D8S1819,
D8S1706
TIE Tie-1 Endothelial cells
Angiopoietin receptors
D1S2743, D1S2722,
D1S197
TEK Tie-2 Endothelial cells
Angiopoietin receptors
VMCM D9S259, D9S1121
NOTCH3 Notch3 Arterial vascular smooth
muscle cells
CADASIL D19S226, D19S917,
D19S929, D19S923[14]
NOTCH2 Notch2 Developing endothelium D1S189, D1S252, D1S514,
D1S2696
NOTCH4 Notch4 Developing endothelium D6S265, D6S258, D6S1624,
D6S276
JAG1 Jagged1 Notch protein ligands Alagille syndrome D20S175, D20S901,
D20S894, D20S186
JAG2 Jagged2 Notch protein ligands D14S292, D14S260,
D14S293, D14S1007
DLL4 Delta4 Notch protein ligands D15S994, D15S1028,
D15S1006
VHL VHL protein Tumor suppressor protein
Anti-angiogenic protein
Von Hippel Lindau disease
Renal clear cell
carcinoma
D3S1435, D3S1317,
D3S1038
4q35ter Unknown AD facio-scapulo-humeral
muscular dystrophy
D4S408, D4S426, D4S2930
3q21 Unknown HERNS D3S3685, D3S3564,
D3S1289
Abbreviations are: BM, basement membrane; GBM, glomerular BM; ECM, extracellular matrix; AD, autosomal dominant; AR, autosomal recessive; BFH, benign
familial hematuria; VMCM, venous malformations, multiple cutaneous and mucosal; CADASIL, cerebral autosomal dominant arteriopathy with subcortical infarct
and leukoencephalopathy; HERNS, hereditary endotheliopathy, retinopathy nephropathy and stroke.
area, without exudate or leakage at late frames of angiog-
raphy (Fig. 3). No other ocular abnormalities were noted.
In particular, there was neither anterior lenticonus and
dot-and-fleck retinopathy, nor signs suggestive of Fabry
disease.
Muscular contractures
All affected patients experienced predominantly prox-
imal muscular contractures from early childhood. Con-
tractures were painful and paroxysmal. They could last
a few seconds to a few minutes, and occasionally a few
hours. Contractures were enhanced by exercise and al-
cohol ingestion. Electromyography was performed in
four patients (III-1, III-3, IV-1, IV-4). Contractures were
recorded in patient IV-4 and were electrically silent.
Muscular testing disclosed only minimal proximal
weakness in two patients (III-1, IV-1), without amy-
otrophia. No other clinical abnormalities were noted on
neurologic examination. Persistently elevated levels of
serum creatine kinase (from 2- to 7-fold the upper limit
of normal) were measured in all patients. A muscular
biopsy was performed in patient III-1. Histologic exami-
nation revealed mild nonspecific muscular changes with-
out signs of metabolic disease, mitochondrial cytopathy,
or microvascular change on ultrastructural examination.
Central nervous system involvement
Patients III-1, IV-1, and IV-2 suffered from recur-
rent headaches, and patient IV-4 presented with a gen-
eralized seizure. Brain MRI disclosed predominantly
posterior asymetrical leukoencephalopathy on FLAIR
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Fig. 2. Renal biopsy specimen of the patient IV-4. (A) Normal glomerulus with numerous erythrocytes in proximal tubule lumen (Trichrome,
magnification ×312). (B) Ultrastructural examination shows a uniform GBM with focal dense folding (→) (original magnification ×3000). Im-
munofluorescence examination with antibodies against a3(IV) collagen chain (C) and a5(IV) collagen chain (D) shows a normal distribution of
a3(IV) and a5(IV) collagen chain (original magnification ×312).
Fig. 3. Fluorescein angiogram of the left eye of patient III-1 shows
typical pattern of retinal tortuosities (→) affecting the second and third
order arterioles, without leakage of the affected vessels. No capillary or
vein abnormalities and micro-aneurysms are observed.
and T2-weighted imaging in patients III-3, IV-2, and IV-4
(Fig. 4). Brain MRI was normal in patient IV-1.
Other manifestations
In addition to renal, muscular, and ocular signs, some
patients presented with other systemic manifestations, in-
cluding Raynaud phenomena with nonspecific capillaro-
scopic changes (patients III-1, III-2, IV-1, IV-2, IV-4), and
symptomatic cardiac arrythmia (patients II-2, III-1 and
IV-1). Mild hypogammaglobulinemia (4.4 to 7.1 g/L) was
also detected in all affected patients from the two last
generations without abnormalities of white blood count.
There was neither macrothrombocytopenia nor leuko-
cyte inclusions on blood smear examination.
Audiometry performed in patients III-2, IV-1, and IV-
2 was normal, and no clinically detectable hearing loss
was observed in other patients. Clinical examination of
the skin was unremarkable in the affected patients. Skin
biopsies were performed in patients III-3 and IV-3. Light
microscopic and ultrastructural study of the biopsy sam-
ples was normal, without arteriolar abnormalities.
Genetic study
Our candidate gene approach was driven by patho-
physiologic hypotheses (Table 1). We first tested genetic
linkage to several genes encoding basement membrane
components coexpressed in the kidney and in the muscle
and vessel walls, including COL4A3/COL4A4, COL1A6,
COL2A6, COL3A6, LAMA5, and FBLN1. We then ex-
tended our linkage analysis to candidate genes involved in
vasculogenesis and angiogenesis processes, including Von
Hippel Lindau gene and genes encoding angiopoietin-
1, angiopoietin-2, Tie-1 and Tie-2 receptors, Notch2,
Notch3, Notch4, and ligands of Notch proteins, including
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Fig. 4. Brain MRI (T2-weighted imaging) shows posterior leukoen-
cephalopathy, which is mild in patient IV-4 (A, B) and more widespread
in patient III-3 (C, D).
Jagged1, Jagged2, Delta4. In addition, we tested linkage
with the locus of the facio-scapulo-humeral dystrophy
4q35ter, and of hereditary endotheliopathy, retinopathy,
nephropathy, and stroke (HERNS) 3q21. The linkage
analyses failed to show segregation of the disease with
any of the tested genes and loci.
DISCUSSION
We report a French Caucasian kindred affected with
a novel syndrome defined by hematuria of glomeru-
lar origin, muscular contractures, and retinal arterio-
lar tortuosities. This syndrome was transmitted as an
autosomal-dominant trait over four generations. All af-
fected members presented with hematuria, muscular con-
tractures, and retinal arteriolar tortuosities, while none
of the family members had contractures or retinal ar-
teriolar tortuosities in the absence of hematuria, which
strongly suggested that a unique gene defect was respon-
sible for those symptoms. However, we cannot definitely
rule out the coexistence of several gene defects in this
family. Some affected members also exhibited MRI brain
abnormalities, Raynaud phenomena, cardiac arrhythmia,
and hypogammaglobulinemia. Most of those manifesta-
tions, especially retinal arteriolar tortuosities and MRI
abnormalities, point to a small vessel vascular disease for
which 18 candidate genes have been investigated by ge-
netic linkage analysis.
One of the most salient features of the syndrome is
hematuria, which appeared during the second decade of
life and remained “isolated” in affected patients of the
third and fourth generations (i.e., without proteinuria,
elevated blood pressure, or renal failure after more than
twenty years follow-up). Partial medical records were
available for patients I-2 and II-2, in whom renal failure
could be related to additional conditions (i.e., acute sepsis
and postoperative shock, respectively). Light microscopy
examination of the kidney biopsy specimen from patient
IV-1 did not show glomerular abnormalities, while red
blood cells filled in some tubular lumens, confirming the
glomerular origin of hematuria. Glomerular expression
of a1, a3, and a5 chains of type IV collagen was nor-
mal, as were ultrastructural aspect and thickness of the
GBM. Finally, haplotype analysis failed to show a linkage
of the disease with the COL4A3/COL4A4 locus. These
results indicated that the syndrome observed was distinct
from usual forms of autosomal-dominant AS and FBH.
The absence of macrothrombocytopenia, and the charac-
teristics of the renal disease, also ruled out Epstein and
Fechtner syndromes, which are caused by mutations in
the MYH9 gene (encoding the nonmuscle myosin heavy
chain IIA) [16–18]. Because cases of AS were shown to
be associated with retinal arteriolar tortuosities [19], the
grouping of clinical signs led us to hypothesize that in our
family, a common molecular defect affecting basement
membranes was responsible for the multisystemic alter-
ations. However, we failed to find a linkage with locus of
genes encoding proteins coexpressed in the glomerular,
muscular, and vascular basement membranes, including
laminin-5, fibulin-1, and a1, a2, and a3 chains of type VI
collagen.
Inherited retinal arteriolar tortuosity with superficial
macular hemorrhages is a well-characterized autosomal-
dominant disorder, although the underlying gene defect
has not been identified so far. The disease has a benign
course without long-term visual impairment, and arte-
riolar abnormalities are apparently limited to the retinal
vascular bed [20, 21]. Retinal arteriolar tortuosity is occa-
sionally observed in Fabry disease [22]. However, the di-
agnosis can be ruled out on the basis of the mode of trans-
mission, and the absence of the characteristic inclusion
bodies of glycolipid in podocytes by electron microscopy.
Retinal arteriolar tortuosity has also been exceptionally
reported in facio-scapulo-humeral dystrophy (FSHD), an
autosomal-dominant muscular disorder characterized by
proximal muscle weakness, amyotrophia, and contrac-
tures [23, 24]. Linkage with the FSHD locus (4q35ter)
was excluded in our family.
In addition to retinal arterial tortuosity observed in
all affected subjects, some of them displayed additional
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clinical signs suggesting a systemic small vessel disease;
indeed, three patients suffered from recurrent headaches,
five patients had Raynaud phenomena, and white mat-
ter signal abnormalities were observed on brain MRI in
three patients. Recently, Vahedi et al reported a kindred
presenting with an autosomal-dominant syndrome that
associated typical retinal arteriolar tortuosity with a cen-
tral nervous system disease, causing infantile hemipare-
sis, migraine with aura, and leukoencephalopathy with
dilation of perivascular spaces on brain MRI, but with-
out hematuria or contractures [25]. This new syndrome
adds to the spectrum of the hereditary cerebral small ves-
sel diseases recently identified [26]. Among them, cere-
bral autosomal-dominant arteriopathy with subcortical
infarct and leukoencephalopathy (CADASIL) is a sys-
temic arteriolopathy affecting mainly cerebral vessels,
rarely retinal vessels [27]. Because CADASIL is due to
mutations in the NOTCH3 gene [20], we, like Vahedi et
al [25], excluded a linkage to the CADASIL/NOTCH3
locus. We also ruled out a linkage with genes encoding
NOTCH2 and NOTCH4 proteins and the NOTCH pro-
tein ligands Jagged1, Jagged2, and Delta4. We have also
tested segregation of the disease with the 3p21 locus, to
which are linked three autosomal-dominant cerebroreti-
nal hereditary syndromes, including the cerebroretinal
vasculopathy, the hereditary vascular retinopathy, and
HERNS, while in the latter conditions, retinal vascu-
lar abnormalities are clearly distinct from the ones
observed in our family [28]. Interestingly, HERNS is
associated with renal involvement including proteinuria,
hematuria, and renal failure [29]. On ultrastructural ex-
amination of HERNS renal biopsy specimens, glomeru-
lar and peritubular capillary basement membranes
presented a multilaminated aspect similar to the one ob-
served in vascular basement membranes in the brain and
other tissues [29], whereas basement membranes were
ultrastructurally normal in patient IV-1 from our family.
We failed to demonstrate a linkage with the 3p21 locus in
our family.
Because we suspected a systemic small vessel disease,
we reasoned that angiogenic proteins could be involved
in podocytes and/or endothelial alterations, leading to ab-
normal permeability of the glomerular capillary wall to
red blood cells. In our family, the increased permeability
of glomerular and retinal arteriole basement membrane
was remarkable for the absence of protein leakage, con-
trary to retinal neovasculogenesis induced by VEGF-A
in proliferative diabetic retinopathy and in animal mod-
els [30, 31]. On the other hand, angiopoietin-1 and -2 and
Tie-1 and Tie-2 receptors are known to induce vasculo-
genesis and inhibit the increased permeability to proteins
caused by VEGF-A [32]. However, linkage analyses with
genes encoding angiopoietin-1 and angiopoietin-2, Tie-1,
and Tie-2 were negative. There was no linkage either to
the Von Hippel Lindau gene.
Muscular symptoms in our patients were characterized
by a painful, transient activation of muscle contraction.
Because no electrical activity was recorded during a mus-
cle contraction on electromyography in one patient, we
concluded that muscular symptoms were muscular con-
tractures. The pathophysiology of contractures remains
obscure. They were painful enough to lead the patients
to consult at the emergency room in pediatric age. They
were different from acroparesthesias observed in Fabry
disease [33]. Because they were associated with vascular
abnormalities, we hypothesize that they could be related
to transient muscular ischemic episodes, given the fact
that they were enhanced by exercise.
CONCLUSION
Our genetic study was limited to the testing of can-
didate genes. A genome-wide linkage analysis would be
more powerful, but would require either a larger pedi-
gree or identification of other families. We recommend
systematically performing a fundus examination in pa-
tients with familial benign hematuria and episodes of vi-
sual impairment, as well as a urinary dipstick analysis
in patients presenting with retinal arterial tortuosity or
congenital muscular contractures. Gene identification of
this novel hereditary disease might help understand the
pathophysiology of some familial hematuria syndromes.
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